Africa’s first COVID-19 ‘vaccine’ manufacturing plant risks shutting down after receiving not a single order.
That’s fantastic news.
WATCH:
Africa’s first Covid vaccine plant risks closure after no orders
africanews pic.twitter.com/9qxUB9ZVOu— Wittgenstein (@backtolife_2022) May 4, 2022
“South Africa’s Aspen Pharmacare negotiated a licensing deal in November to package and sell Johnson & Johnson’s COVID-19 vaccine and distribute it across Africa,” Reuters reports.
But the plant, touted as a ‘trailblazer’ to inoculate the continent, hasn’t received a single order.
“Africa’s first COVID-19 vaccination plant, touted a trailblazer for an under-vaccinated continent, risks shutting down after receiving not a single order” RT
South Africa’s Aspen COVID-19 vaccine plant risks closure after no ordershttps://t.co/anL3a162H8— The HighWire (@HighWireTalk) May 3, 2022
Production at Africa’s largest Covid19 vaccine manufacturing plant has been halted for the past month. Almost no takers for the vaccines. Whatever happened to all those vaccine inequity warriors? https://t.co/m8iDHskOxo
— Rupa Subramanya (@rupasubramanya) May 3, 2022
What happens when vast majority don’t need or want your product…https://t.co/t5u8McU6rf
— Ivor Cummins (@FatEmperor) May 2, 2022
From Reuters:
The World Health Organization (WHO) called the deal a “transformative moment” in the drive towards levelling stark inequalities in access to COVID vaccines.
With only a sixth of adults in Africa fully vaccinated, according to the latest WHO figures from the end of March, Aspen’s agreement to sell an Aspen-branded COVID-19 vaccine, Aspenovax, throughout Africa seemed like a sure bet.
South Africa, which has vaccinated 30% of its population, also looks set to experience a fifth wave of infections.
Africanews added:
Professor Tulio de Oliveira, the director of the Centre for Epidemic Response and Innovation in South Africa, told the BBC that the closure could affect the production of other vaccines that “do not affect the developed world” as well as the preparation for the next pandemic.
It is the aim of the African union that 60% of all vaccines would be produced in Africa, however, with the latest development, Africa is at risk of missing this target.
Maybe Africans don’t want their poison shots.
Haven’t they figured that’s the reason Aspen Pharmacare hasn’t received a single order for the COVID-19 shot?
However, their inflated egos won’t allow them to see this reality.
